Login
To share your thoughts
Don't have an account?
Check your inbox
We just sent a link to your inbox. Click the link to continue signing in. Can’t find it? Check your spam & junk mail.
Didn't get a link?
Sign up
Ready to get started
Already have an account?
Check your inbox
We just sent a link to your inbox. Click the link to continue registering. Can’t find it? Check your spam & junk mail.
Didn't get a link?
Join Rappler+
How often would you like to pay?
Monthly Subscription
Your payment was interrupted
Exiting the registration flow at this point will mean you will loose your progress
Your payment didn’t go through
Exiting the registration flow at this point will mean you will loose your progress
Moderna's COVID-19 mRNA vaccine is likely to offer protection of up to a couple of years, its chief executive said on Thursday, January 7, even though more data is still needed to make a definitive assessment.
The US biotech company, which stunned the world last year by coming up with a vaccine against the disease caused by the new coronavirus in just a few weeks, received approval for its shot from the European Commission on Wednesday, January 6.
Given vaccines development and pharmacovigilance usually requires years, the protection duration of COVID-19 shots is a lingering question for scientists and regulators.
"The nightmare scenario that was described in the media in the spring with a vaccine only working a month or two is, I think, out of the window," Moderna CEO Stephane Bancel said at an event organized by financial services group Oddo BHF.
"The antibody decay generated by the vaccine in humans goes down very slowly (…) We believe there will be protection potentially for a couple of years."
Bancel added his company was about to prove that its vaccine would also be effective against variants of the coronavirus seen in Britain and South Africa.
Scientists have said newly developed vaccines should be equally effective against both variants. – Rappler.com